Abstract
Studies on nematodosis and arachnoentomosis of farm animals were carried out in the Ryazan and Kursk regions and the effectiveness of the drug IVERSAN® (OOO AVZ S-P) was studied. Clinical examination and laboratory tests revealed the following diagnoses: ostertagiosis, chabertiosis, nematodirosis, esophagostomiasis, bunostomiasis, strongyloidiasis and melophagosis in sheep and calves; ascariasis, esophagostomiasis, strongyloidiasis, balantidiasis and sarcoptosis of piglets; delafondiosis, alfortiosis, strongylosis, trichonematidosis, strongyloidiasis and bovicolosis of horses. Ivermectin containing a broad-spectrum preparation IVERSAN® at a dose of 1 ml per 100 kg of body weight individually orally with water is effective for cattle and sheep with nematodes and melophagosis (EE=100 %); equally at the same dose in a group way - against nematodes and sarcoptoid mites of pigs (EE=100 %); at a dose of 1 ml/200 kg individually orally with water for horses against strongylates of the gastrointestinal tract, strongyloides (EE=91,6–100 %) and withers (EE=100 %). In animals of the control groups, the indicators of the extensiveness and intensity of invasion did not change significantly during the experiments. An increase in the dose of parasiticide IVERSAN®by 1,5–2 times, compared with the recommended therapeutic one, does not cause toxicosis, allergic reactions and complications in piglets of 2,5 months of age. The timing and frequency of use of an ivermectin-containing drug for helminthiases and arachnoentomosis in livestock enterprises, equestrian clubs and in farms and individual farms have been developed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.